Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

181
 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Copenhagen Stock Exchange
11/21/2014 11/24/2014 11/25/2014 11/26/2014 11/27/2014 Date
265.8 266.5 266.5 267 269.7 Last
1768251 1380361 3075473 1559591 1019719 Volume
+0.76% +0.26% 0.00% +0.19% +1.01% Change
Company
Novo Nordisk AS is engaged in the development, manufacture, and marketing of pharmaceutical products.It operates through the Diabetes Care and Biopharmaceuticals segments.The Diabetes Care segment deals with the research, development, manufacture, and marketing of products within the areas of... 
Sector
Pharmaceuticals
Calendar
12/04Presentation
Surperformance© rating of Novo Nordisk A/S
Trading Rating : Investor Rating :
More about the company
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Full-screen chart
Financials ( DKK)
Sales 2014 88 464 M
EBIT 2014 33 977 M
Net income 2014 26 319 M
Finance 2014 10 691 M
Yield 2014 1,78%
Sales 2015 97 893 M
EBIT 2015 38 839 M
Net income 2015 29 612 M
Finance 2015 11 683 M
Yield 2015 2,04%
PER 2014 26,69
PER 2015 23,17
EV / Sales 2014 6,26x
EV / Sales 2015 5,64x
Capitalization 564 055 M
More Financials
Latest news on NOVO NORDISK A/S
1d ago NOVO NORDISK A/S : Findings from Novo Nordisk Reveals New Findings on Hematology..
1d ago NOVO NORDISK A/S : Case Study Shows Path to Lowering Costs and Improving Diabete..
1d ago NOVO NORDISK A/S : Study Results from Novo Nordisk Provide New Insights into Dia..
1d ago NOVO NORDISK A/S : Details Findings in Proinsulin (Changes in Glucose and Fat Me..
2d ago ELI LILLY : Gets European Approval to Sell Trulicity, a Type 2 Diabetes Drug
2d ago NOVO NORDISK A/S : Changes in Novo Nordisk's Executive Management
3d ago NOVO NORDISK A/S : Changes in Novo Nordisk's Executive Management
3d ago NOVO NORDISK A/S : Changes in Novo Nordisk's Executive Management
3d ago NOVO NORDISK A/S : Grant Enables Trenton Health Team to Engage Faith-Based Organ..
3d ago NOVO NORDISK A/S : Victoza gets CHMP positive opinion to treat adults with type ..
3d ago NOVO NORDISK A/S : Share repurchase programme
3d ago Novo Nordisk A/S - Share repurchase programme
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF